GENE PANEL MARKET ANALYSIS

Gene Panel Market, by Technique (Amplicon-Based and Hybridization-Based), by Design (Predesigned Gene Panels and Customized Gene Panels), by Application (Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, and Others), by End User (Research and Academic Institutes, Hospital and Diagnostic Laboratories, and Biotechnology and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Jul 2021
Code : CMI4545
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Gene Panel MarketSize and Trends

Figure 1: Global Gene Panel Market Share (%) Analysis, By Technique, 2021

The increasing burden of chronic diseases is the major factor that is expected to drive the market growth of gene panel over the forecast period.

The rising burden of chronic diseases which are associated with genes such as stroke, heart attack, cancer, arthritis, and others are expected to drive growth of gene panel market over the forecast period. According to the data provided by the International Agency for Research on Cancer (IRAC) in 2018, it is estimated that there will be more than 27.5 million new cancer cases by 2040, which would be majorly due to factors such as unhealthy lifestyle, smoking, and reduced physical activities. Also, according to the statistics provided by the World Health Organization in 2018, over 795,000 people have stroke each year in the U.S. This is expected to create opportunities for gene panel market as a clinical diagnostic tool.

The rising number of product launch and approval is expected to drive the growth of the global gene panel market over the forecast period. For instance, in September 2020, Bionano Genomics, an American genomic diagnostics manufacturer, announced the launch of EpiPanelDx PLUS, which is a gene panel test for diagnosis of epilepsy.